O'Brien Stephen Paul bought TVRD
January 29, 2026 · Form 4 insider transaction
O'Brien Stephen Paul bought 15,000 shares of Tvardi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$0.00
Total value
N/A
InsiderO'Brien Stephen Paul
RoleOfficer
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 29, 2026
Filing dateFebruary 2, 2026
Shares owned after15,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest and become exercisable in equal monthly installments over 48 months commencing on January 29, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.